Financhill
Buy
56

KALV Quote, Financials, Valuation and Earnings

Last price:
$15.80
Seasonality move :
10.02%
Day range:
$15.44 - $16.17
52-week range:
$7.30 - $17.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
54.78x
P/B ratio:
46.95x
Volume:
307.3K
Avg. volume:
1.5M
1-year change:
80.25%
Market cap:
$798.1M
Revenue:
--
EPS (TTM):
-$4.01

KALV Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for KalVista Pharmaceuticals, Inc. shares anticipate an average target of $31.00, ranging from a low estimate of $22.00 to a high estimate of $39.00. This average target implies a growth of 96.33% compared to the current stock price of $15.79.

Consensus Price Target

$31.00

Highest Price Target

$39.00

Lowest Price Target

$22.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 7 7

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

KALV Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock